Article Details

Adaptimmune Therapeutics (NASDAQ:ADAP) Upgraded to “Hold” by BidaskClub

Retrieved on: 2018-12-21 13:46:04

Tags for this article:

Click the tags to see associated articles and topics

Adaptimmune Therapeutics (NASDAQ:ADAP) Upgraded to “Hold” by BidaskClub. View article details on hiswai:

Excerpt

<div><b>Sofinnova Ventures</b> Inc acquired a new stake in Adaptimmune Therapeutics during the 3rd quarter worth about $1,220,000. Finally, Man Group plc ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo